Karen S. Lynch is an American health care executive best known as the former president and CEO of CVS Health. She took that role in February 2021 and stepped down in October 2024. As of September 2026, she is a director at Thermo Fisher Scientific; Thermo Fisher also lists ADP among her current directorships. She is not the current CEO of CVS Health.
That distinction is useful when reading profiles of Lynch. Some institutional biographies still describe her as CVS Health’s CEO. They reflect an earlier point in her career, while the company’s dated leadership announcement establishes when the role changed.
| Period | Documented role or milestone |
|---|---|
| Early career | Certified public accountant at Ernst & Young |
| 2015–2021 | President of Aetna |
| February 2021–October 2024 | President and CEO of CVS Health |
| 2024 | Published Taking Up Space |
| 2025 onward | Director at Thermo Fisher Scientific |
| September 2026 | Also listed as an ADP director |
The dates and roles above come from company, publisher and university records.
From accounting to health care leadership
Lynch began her career as a certified public accountant at Ernst & Young. She later held executive positions at Cigna and Magellan Health Services before joining Aetna in 2012. She became Aetna’s president in 2015 and continued in that role after CVS Health acquired the insurer in 2018.
Her education combined accounting and management. ADP’s professional biography identifies a bachelor’s degree from Boston College and an MBA from Boston University. That background helps explain the path from financial work to leadership at large health care companies.
When did Karen S. Lynch become CVS Health CEO?
CVS Health announced in November 2020 that Lynch would succeed Larry Merlo. Her appointment as president and CEO took effect on February 1, 2021. Before the promotion, she was already an executive vice president at CVS Health as well as president of Aetna.
The move put her in charge of a business spanning pharmacies, insurance and pharmacy benefit services. It also made her one of the most prominent women leading a major U.S. corporation. Lynn University later described her recognition on Fortune’s Most Powerful Women in Business list during her time at CVS Health.
Why did she leave CVS Health?
On October 18, 2024, CVS Health announced that David Joyner had become president and CEO effective the previous day. The company said Lynch had stepped down in agreement with its board of directors. Its announcement also discussed elevated medical costs and changes to its financial outlook.
Those are the documented facts. Describing a single financial result, personal disagreement or outside rumor as the sole reason for her departure would go further than the company’s statement supports. The CVS Health leadership announcement provides the precise date and wording of the transition.
What does Karen S. Lynch do now?
Lynch’s public professional record continued after CVS Health. Thermo Fisher Scientific’s director profile lists her as a director since 2025 and names ADP as another current directorship. The profile describes her CVS leadership, Aetna experience and accounting background as qualifications for board service.
ADP announced her board nomination in September 2025. Its announcement at that time confirmed her Thermo Fisher directorship and summarized her earlier roles. This is a more useful account of her recent work than an older speaker profile that still presents her as CVS CEO.
Her book and work with Lynn University
Lynch wrote Taking Up Space: Get Heard, Deliver Results, and Make a Difference, a leadership book published in 2024. McGraw Hill’s listing identifies her as the author and describes its focus on making oneself heard and leading through difficult decisions. Its promotional description was written while she held the CVS CEO role, so it should not be read as a current job title.
Lynch and her husband, Kevin, also made a $5 million gift to Lynn University, according to the university. Lynn’s account of the gift describes plans to support students, including a Karen S. Lynch Endowed Scholarship. A publicly announced gift documents a philanthropic commitment; it does not, by itself, establish Lynch’s personal net worth.
Is Karen S. Lynch connected to Elizabeth Taylor?
Readers may encounter the two names together online. Lynch is the former health care executive described here; Elizabeth Taylor was an actress and HIV/AIDS advocate. No documented family or professional relationship between them has been established. Our separate article examines the question of a Karen Lynch and Elizabeth Taylor connection.
Frequently asked questions
Is Karen S. Lynch still the CEO of CVS Health?
No. Lynch stepped down in October 2024, and David Joyner succeeded her. CVS Health’s own announcement confirms the transition.
What is Karen S. Lynch’s net worth?
No verified personal net-worth figure is publicly established. Executive compensation disclosures describe pay for particular years, but they do not reveal a complete picture of someone’s assets, debts, taxes and investments. Her Lynn University gift should not be converted into a wealth estimate.
Where can readers find a general biography?
The company and university records linked above provide the strongest support for her career dates and current roles. Karen S. Lynch’s Wikipedia biography offers a broader starting point, but its details should be checked against dated primary records when current status matters.
Karen S. Lynch’s career today
Lynch’s defining executive role was leading CVS Health from 2021 to 2024. Her documented work since then includes corporate directorships, her leadership book and support for Lynn University students. For an accurate current description, former CVS Health CEO and corporate director is more precise than calling her CVS Health’s CEO today.